FODOZAN Trademark

Trademark Overview

On Wednesday, March 14, 2007, a trademark application was filed for FODOZAN with the United States Patent and Trademark Office. The USPTO has given the FODOZAN trademark a serial number of 77131316. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Friday, April 26, 2013. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The FODOZAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, preparations and substances for the treatment of cancers and immunological diseases and disorders, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas and immunological disorders such as transplant rejection
fodozan

General Information

Serial Number77131316
Word MarkFODOZAN
Filing DateWednesday, March 14, 2007
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateFriday, April 26, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2007

Trademark Statements

Goods and ServicesPharmaceutical products, namely, preparations and substances for the treatment of cancers and immunological diseases and disorders, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas and immunological disorders such as transplant rejection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 19, 2007
Primary Code005
First Use Anywhere DateMonday, December 11, 2006
First Use In Commerce DateMonday, December 11, 2006

Trademark Owner History

Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBirmingham, AL 352441879
Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 352441879

Trademark Events

Event DateEvent Description
Friday, April 26, 2013ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Friday, April 26, 2013ABANDONMENT - AFTER EX PARTE APPEAL
Friday, April 26, 2013EXPARTE APPEAL TERMINATED
Friday, February 8, 2013EX PARTE APPEAL-REFUSAL AFFIRMED
Wednesday, June 20, 2012NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Wednesday, June 20, 2012EXAMINERS STATEMENT E-MAILED
Wednesday, June 20, 2012SU - EXAMINER STATEMENT - WRITTEN
Tuesday, May 1, 2012JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, February 24, 2012EX PARTE APPEAL-INSTITUTED
Friday, February 24, 2012EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, August 31, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 31, 2011FINAL REFUSAL E-MAILED
Wednesday, August 31, 2011SU - FINAL REFUSAL - WRITTEN
Friday, August 12, 2011AMENDMENT FROM APPLICANT ENTERED
Friday, August 12, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 8, 2011ASSIGNED TO LIE
Friday, July 29, 2011PAPER RECEIVED
Thursday, January 27, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 27, 2011NON-FINAL ACTION E-MAILED
Thursday, January 27, 2011SU - NON-FINAL ACTION - WRITTEN
Wednesday, January 5, 2011STATEMENT OF USE PROCESSING COMPLETE
Saturday, December 11, 2010USE AMENDMENT FILED
Monday, December 13, 2010TEAS STATEMENT OF USE RECEIVED
Saturday, June 12, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 11, 2010EXTENSION 5 GRANTED
Wednesday, June 9, 2010EXTENSION 5 FILED
Wednesday, June 9, 2010TEAS EXTENSION RECEIVED
Thursday, September 24, 2009EXTENSION 4 GRANTED
Monday, September 21, 2009EXTENSION 4 FILED
Monday, September 21, 2009TEAS EXTENSION RECEIVED
Thursday, June 25, 2009EXTENSION 3 GRANTED
Wednesday, June 3, 2009EXTENSION 3 FILED
Thursday, June 25, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 3, 2009TEAS EXTENSION RECEIVED
Wednesday, December 10, 2008EXTENSION 2 GRANTED
Wednesday, December 10, 2008EXTENSION 2 FILED
Wednesday, December 10, 2008TEAS EXTENSION RECEIVED
Tuesday, June 3, 2008EXTENSION 1 GRANTED
Tuesday, June 3, 2008EXTENSION 1 FILED
Tuesday, June 3, 2008TEAS EXTENSION RECEIVED
Tuesday, December 11, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 18, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2007NOTICE OF PUBLICATION
Friday, August 10, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 10, 2007ASSIGNED TO LIE
Tuesday, June 26, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 25, 2007ASSIGNED TO EXAMINER
Monday, March 19, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

fodozan cell immunological disorders namely such cancers leukemias rejection transplant lymphomas